Tech Nation + BioTech Nation + Global BioEntrepreneurship
Weekly Public Radio Program & Podcast
Episode 26-18 Air Date: May 5, 2026
On this week’s Tech Nation, we celebrate the 50th anniversary of the first biotech company to go public, Genentech. Moira speaks with CEO Ashley Magargee about the company’s journey since its founding 50 years ago, and where they’re going next. Then, we remember the life of the late Dr. Craig Venter, whose efforts catalysed the race to decode the first human genome.
Episode 26-17 Air Date: April 30, 2026
On this week’s Tech Nation, Moira speaks with Google’s Data Editor Simon Rogers about the questions we’ve all asked Google over the years…and the surprising truths they reveal about our shared humanity.Then, Andrew Farnum and Sarah Le Baron von Baeyer discuss how Variant Bio aims to forge partnerships with communities not often represented in genomic research. Could studying the genes of isolated populations lead to more effective therapies? And how might they be ethically compensated for their contributions?
Episode 26-16Air Date: April 22, 2026
On this week’s Tech Nation, NYU professor Dr. Christine Webb talks about “The Arrogant Ape: The Myth of Human Exceptionalism and Why It Matters”. And one biotech company's efforts to help pre-term babies. Dr. Marc Salzberg, CEO & Chief Medical Officer of Airway Therapeutics, talks about their late-stage testing, getting a single protein as soon as these babies are born.
BioTech Nation PODCASTS
May 5, 2026
Ashley Magargee CEO, Genentech
This week on BioTech Nation, we celebrate the 50th anniversary of Genentech, the first biotech company to go public. Moira speaks with CEO Ashley Magargee about the company's journey over the last 50 years, the evolution of biotech, and where they're headed next.
April 28, 2026
Andrew Farnum & Sarah LeBaron von Baeyer, Variant Bio
  • This week on BioTech Nation, Andrew Farnum and Sarah LeBaron von Baeyer discuss Variant Bio’s unique approach to collecting genetic data - working specifically with indigenous tribes and more isolated populations around the globe. Could compiling this diverse genetic data reveal something about how to develop better drugs and diagnostics? And how might those sharing their data be ethically compensated for it?

The J.P. Morgan Healthcare Conference 2026
5 Companies Ready to Make A Difference
In San Francisco, biotech entrepreneurs, innovators, and investors from all over the globe are gathering at the 44th Annual J.P. Morgan Healthcare Conference. To coincide with the conference, we’ve put together a special release of 5 BioTech Nation interviews…
These are the JP Morgan Conference 2026 BioTech Nation “5”!
We hear from 5 unique BioTech companies ready to make a difference. Hear their stories directly from the founders, CEOs, and scientists that are making waves in the biotech world:
💡 A New Way to Treat Cancer - Cyriac Roeding & Dr. David Suhy, Earli
💡 A Speedy Intervention for Heart Attacks - Dr. Harry Selker & Atul Deshpande Ph.D., MBA, A-PMP, IMMEDIATE Therapeutics
💡 A Fast-Acting Dupixent? - Dr. Barry Quart, Connect Biopharma
💡 You’ve Had Back Pain for 7-10 Years?- Neil Klompas, Augurex Life Sciences Corp.
💡 A Euphoria-Suppressing Opioid - Ketan Mehta, Tris Pharma
Industry Insights. Startup Directory. Academic Journal. More Information coming soon.